Biodesix (BDSX) Gross Profit (2019 - 2026)

Biodesix (BDSX) has 8 years of Gross Profit data on file, last reported at $21.3 million in Q1 2026.

• Quarterly Gross Profit rose 49.77% year-over-year to $21.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $78.9 million (up 35.15% YoY) and the FY2025 annual result came in at $71.8 million, up 28.75% from the prior year.
• Gross Profit declined to $21.3 million in Q1 2026, from $23.9 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $23.9 million in Q4 2025 to a low of $3.3 million in Q1 2022.
• A 5-year average of $12.3 million and a median of $11.6 million in 2024 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2022 — Gross Profit slumped 68.89% — and 2024, when it soared 97.77%.
• Tracing BDSX's Gross Profit over 5 years: stood at $6.3 million in 2022, then jumped by 79.24% to $11.3 million in 2023, then jumped by 42.44% to $16.1 million in 2024, then jumped by 48.42% to $23.9 million in 2025, then fell by 10.58% to $21.3 million in 2026.
• The last three Gross Profit figures came in at $21.3 million (Q1 2026), $23.9 million (Q4 2025), and $17.7 million (Q3 2025), per Business Quant data.